Paediatric follicular lymphoma
Massive haemolysis and methaemalbuminaemia in a patient with decompensated haemoglobin H disease
Prospects for the provision of genotyped blood for transfusion
Cellular immune dysfunction in immune thrombocytopenia (ITP)
Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas
Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype
The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways
Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia
Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor *
Respiratory muscle force and lung volume changes in a population of children with sickle cell disease
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Gonadal function in patients with severe aplastic anaemia and refractory cytopenia of childhood who undergo bone marrow transplantation after receiving 3-Gy total body irradiation and high-dose cyclophosphamide
A model for prediction of FLT3 -ITD and NPM1 (without FLT3 -ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
Allogeneic stem cell transplantation as immunotherapy for X-linked lymphoproliferative disease-associated cerebral T-cell lymphoma
The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models
ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets
Adipocytokines are related to haemolytic and inflammatory biomarkers in sickle cell beta thalassaemia
Announcement